Last reviewed · How we verify

NCT04455971

Orgasmic Meditation and Sleep Quality

Completed Last updated 10 May 2021
What this trial tests

trial testing Orgasmic Meditation in Sleep in 46 participants. Completed in 15 April 2021.

Timeline
6 October 2020
Primary endpoint
15 April 2021
15 April 2021

Quick facts

Lead sponsorInstitute of OM Foundation
StatusCompleted
Study typeOBSERVATIONAL
Enrollment46
Start date6 October 2020
Primary completion15 April 2021
Estimated completion15 April 2021
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Institute of OM Foundation

Who can join

18 and older, any sex, with Sleep. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary purpose of this study is to use an observational design to examine whether the practice of orgasmic meditation (OM) is associated with app-based measures of sleep quality. A secondary purpose of this study is to examine whether the occurrence of physiological orgasm during OM practice is associated with app-based measures of sleep quality. It is hypothesized that the practice of OM will have a positive impact on sleep quality.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Orgasmic Meditation

Trials testing the same drug.

Other recruiting trials for Sleep

Currently open trials in the same condition.

Other Institute of OM Foundation trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04455971.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing